Guangzhou Trauer Biotechnology Co., Ltd.
标题
标题
Home
>
News
>
Company News
>
Trauer Biotech Welcomes Thai FDA and FTI Delegation for Exchange on Atelocollagen Innovation and Biomedical Applications
Trauer Biotech Welcomes Thai FDA and FTI Delegation for Exchange on Atelocollagen Innovation and Biomedical Applications
Prev:
Major Breakthrough by Trauer Biotech: First-Generation Recombinant Type III Human Collagen Preparation Technology Leads a New Era in Medical Aesthetics
Next:
New Launch: Low Endotoxin atelocollagen Sponge S! Raw Material (<0.02 EU/mg)
